July 3, 2026, 1:55 PM EDT. Avita Medical Inc. (RCEL) was bumped up to a Zacks Rank #2 (Buy) after analysts raised earnings estimates, pointing to a more bullish outlook. Zacks tracks EPS forecast changes to gauge near-term stock moves based on where institutional money is going. For the year ending December 2026, Avita Medical's EPS is pegged at -$1.09, flat against last year, but the recent wave of estimate revisions has given the stock a boost. The move could bring shares higher as investors react to the improved earnings view.
